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Abstract: Nuclear factor kappa B (NF-kB) is one of the most important transcription factors whose 
modulation triggers a cascade of signaling events, namely the expression of many cytokines, enzymes, chemokines, and 
adhesion molecules, some of which being potential key targets for intervention in the treatment of inflammatory condi-
tions. The 2-styrylchromones (2-SC) designation represents a well-recognized group of natural and synthetic chromones, 
vinylogues of flavones (2-phenylchromones). Several 2-SC were recently tested for their anti-inflammatory potential, re-
garding the arachidonic acid metabolic cascade, showing some motivating results. In addition, several flavones with struc-
tural similarities to 2-SC have shown NF-kB inhibitory properties. Hence, the aim of the present work was to continue the 
investigation on the interference of 2-SC in inflammatory pathways. Herein we report their effects on lipopolysaccharide 
(LPS)-induced NF-kB activation and consequent production of proinflammatory cytokines/chemokine, using a human 
monocytic cell line (THP-1). From the twelve 2-SC tested, three of them were able to significantly inhibit the NF-kB acti-
vation and to reduce the production of the proinflammatory cytokines/chemokine. The compound 3’,4’,5-trihydroxy-2-
styrylchromone stood up as the most active in both assays, being a promising candidate for an anti-inflammatory drug. 
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1. INTRODUCTION 
Nuclear factor kappa B (NF-kB) is one of the most im-
portant transcription factors whose modulation triggers a 
cascade of signaling events, some of which are potential key 
targets for intervention in the treatment of inflammatory 
conditions. In addition, NF-kB activation has been linked to 
the carcinogenesis process because of its role in differentia-
tion, inflammation and cell growth [1]. 
In resting cells, NF-kB, which is composed mainly of 
two proteins, p50 and p65, is present within the cytoplasm in 
an inactive state, bound to its inhibitory protein, IB. How-
ever, a number of proinflammatory stimuli [cytokines such 
as tumour necrosis factor (TNF)- or interleukin (IL)-1, oxi-
dative stress, infectious agents] can activate NF-kB in differ-
ent cell types. These inflammatory stimulations can initiate 
an intracellular signaling cascade leading to IB phos- 
phorylation, by IB kinase (IKK) complex, with its subse-
quent dissociation from NF-kB and degradation by the 
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proteasome. Once liberated from its inhibitory protein, NF-
kB translocates to the nucleus, where it orchestrates the tran-
scription of a number of proinflammatory genes by binding 
to B motifs found in the promoter or enhancer region. This 
activates the expression of many mediators of the inflamma-
tion including, cytokines, enzymes, chemokines, and adhe-
sion molecules [2]. 
Lipopolysaccharide (LPS) is a surface component of 
gram-negative bacteria released upon host infection. Its in-
teraction with Toll-like receptor 4 (TLR4), located in cell 
membrane, initiates a signal transduction pathway, which 
leads, among other events, to the activation of NF-kB [3]. In 
monocytes, LPS-dependent activation of NF-kB complexes 
induces a rapid but transient expression of a defined set of 
genes including TNF-, IL-1, IL-6 and IL-8 [4]. These 
proinflammatory mediators have shown to play important 
roles in the pathogenesis of chronic inflammatory and auto-
immune diseases such as rheumatoid arthritis, inflammatory 
bowel disease, or multiple sclerosis [5-8]. 
The 2-styrylchromones (2-SC) designation represents a 
well recognized group of natural and synthetic chromones, 
vinylogues of flavones (2-phenylchromones). As it occurs 
for flavones, several studies performed with 2-SC have dis-
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closed interesting activities with potential therapeutic appli-
cations, namely, neuroprotective action [9] and possible use 
in the treatment of cancers [5-8, 10-13], allergies [14], viral 
infections [15-17], gout [18] and oxidative stress related 
damage [19]. In fact the antioxidant properties of 2-SC have 
been shown in cellular [19] and non-cellular systems [20, 
21]. In a recent study, performed by our group, a number of 
2-SC were shown to have anti-inflammatory potential by 
inhibiting both the production of leukotriene B4 in human 
neutrophils and the activity of the enzyme cyclooxygenase 
(COX)-1 in a non-cellular system [22]. Those promising 
results lead us to continue the investigation on the interfer-
ence of 2-SC (Fig. 1) in inflammatory pathways. Herein we 
report their effects on LPS-induced NF-kB activation and 
production of TNF-, IL-1, IL-6 and IL-8 due to the above 
mentioned relevance of the NF-kB pathway in the inflamma-
tory process and also to the fact that several flavonoids with 
structural similarities to 2-SC have shown interesting results 
in this field (see [23, 24] for reviews). The present studies 
were performed with the human monocytic leukemia cell 
line (THP-1). These cells were chosen because they display 
many characteristics similar to human monocytes and have 
been used previously to study the inflammatory process [4, 
25-28]. 
1A: R1 = R2 = OH
1B: R1 = H, R2 = OH
1C: R1 = OH, R2 = H
1D: R1 = R2 = H
O
O
2A: R1 = R2 = OH
2B: R1 = H, R2 = OH
2C: R1 = OH, R2 = H
2D: R1 = R2 = H
R2
R1
OH
O
O
3A: R1 = R2 = OH
3B: R1 = H, R2 = OH
3C: R1 = OH, R2 = H
3D: R1 = R2 = H
R2
R1
O
OR1
OH
A C
B
2
3
45
6
7
8


2' 3' OH
4'5'
6'
R2
Group 1
Group 2
Group 3
 
Fig. (1). Chemical structures of the tested 2-SC. 
2. MATERIAL AND METHODS 
2.1. Reagents 
THP-1 cells, RPMI 1640 medium, penicillin-
streptomycin, L-glutamine, fetal bovine serum (FBS), igepal, 
dithiothreitol, phenylmethanesulfonyl fluoride, aprotinin, 
leupeptin, pepsatin, and LPS from Escherichia Coli O26:B6 
were obtained from Sigma-Aldrich (St Louis, MO). All the 
reagents used were of analytical grade. 
2-Styrylchromones 1A-1D, 2A-2D and 3A-3D were syn-
thesised by the three step Baker-Venkataraman method, 
starting from the O-protected 2’-hydroxyacetophenones and 
cinnamoyl chlorides [29]. The first step involves the O-
acylation of the appropriate 2’-hydroxyacetophenones with 
cinnamoyl chloride derivatives to give 2’-cinnamoylo-
xyacetophenones. These intermediates were converted into 
5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-ones by 
the base-catalysed Baker-Venkataraman rearrangement [30-
32]. The cyclodehydration of these -diketones with a mix-
ture of DMSO and a catalytic amount of iodine or p-
toluenesulfonic acid gives polybenzyloxy-2-SC, which were 
debenzylated by treatment with hydrogen bromide in acetic 
acid at reflux, to give the expected hydroxy-2-SC 1A-1D, 
2A-2D and 3A-3D, with NMR spectra identical to those in 
the cited literature. 
2.2. Equipment 
A microplate reader (Synergy HT, BIO-TEK), was used 
to perform the chemiluminescence and absorbance readings. 
2.3. Cell Culture 
THP-1 cells were maintained in RPMI 1640 medium 
supplemented with penicillin (100 U/mL), streptomycin (100 
g/mL), L-glutamine (2 mmol/L) and 10% FBS in a 5% CO2 
humid atmosphere at 37°C.  
2.4. NF-kB Activation  
THP-1 cells (1x106 cells/mL) were cultivated in 6-well 
plates and incubated with the test compounds or vehicle 
(DMSO) for 90 min and subsequently stimulated with LPS 
(0.1 g/mL) for 30 min. The nuclear extracts were then ob-
tained according to a previously described method [33] with 
minor modifications. Cells were collected on ice, centrifuged 
(870 x g) at 4ºC, for 5 min, and ressuspended in 1 mL of cell 
lysis buffer [10 mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM 
KCl, 0.5 mM EDTA, 0.1 mM EGTA] supplemented with 
2% igepal, 1 mM dithiothreitol and 0.25 mM phen-
ylmethanesulfonyl fluoride. The samples were then incu-
bated on ice for 15 min and centrifuged (13,000 x g) at 4ºC, 
for 5 min. The supernatant was removed and the nuclear 
pellets were ressuspended in 100 L of nuclear lysis buffer 
solution [20 mM Hepes (pH 7.9), 420 mM NaCl, 1.5 mM 
MgCl2, 0.5 mM EDTA, and 20% glycerol] supplemented 
with 1 mM dithiothreitol, 0.25 mM phenylmethanesulfonyl, 
and 5 g/mL of each of the following protease inhibitors: 
aprotinin, leupeptin, and pepsatin. The mixture was kept on 
ice for 30 min, under intermittent agitation, and further cen-
trifuged (13,000 x g) at 4ºC, for 10 min. The supernatant was 
collected and stored at -80ºC. The protein content was meas-
ured using the DC Bio-Rad protein assay kit (Bio-Rad Labo-
ratories, Hercules, California, USA). 
The activated NF-kB contained in the nuclear extracts 
was measured by immunoassay, using a commercially avail-
able ELISA kit (Trans AM NF-kB p50 chemi) from Active 
Motif (Carlsbad, CA), according to the manufacturer’s in-
structions. Briefly, NF-kB was captured by binding to a con-
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sensus oligonucleotide (5-GGGACTTTCC-3) immobilized 
on a 96-well plate. The p50 subunit of NF-kB was deter-
mined by a chemiluminescent reaction using a specific pri-
mary antibody and a secondary horseradish peroxidase-
conjugated antibody. The results were expressed as the re-
duction of p50-dependent chemiluminescence signal rela-
tively to control (%). 
2.5. Cytokines/Chemokine Production 
THP-1 cells (1x106 cells/mL) were cultivated in 6-well 
plates and incubated with the test compounds or vehicle 
(DMSO) for 90 min and subsequently stimulated with LPS 
(0.1 g/mL) for 14 h. The cultures were then collected into 
microcentrifuge tubes and centrifuged (1,000 x g) for 10 
min. The supernatant was assayed for secreted cytokines 
(TNF-, IL-1, and IL-6), and chemokine (IL-8) using a 
commercially available ELISA Kit from SABiosciences 
(Frederick, MDbe), according to the manufacturer’s instruc-
tions. The detection was made by reading the absorbance at 
450 nm. The results were expressed as the reduction of cyto-
kines/chemokine-dependent absorption at 450 nm relatively 
to control (%). 
2.6. Cytotoxicity 
The effect of the 2-SC on the cell viability was assessed 
by the lactate dehydrogenase (LDH) leakage (as a measure 
of cell membrane integrity). The LDH activity was deter-
mined by following the rate of oxidation of NADH at 340 
nm [34]. 
2.7. Statistical Analysis 
The statistical analysis was performed by one-way analy-
sis of variance (ANOVA) followed by Dunnett’s multicom-
parison test using GraphPad Prism version 5.00 for Win-
dows, GraphPad Software, San Diego California, USA, 
http://www.graphpad.com. When comparing with control 
group, values of P less than 0.05 were considered significant. 
3. RESULTS 
3.1. NF-kB Activation 
Among the tested 2-SC from group 1, compound 1C was 
the most active, inhibiting the NF-kB activation in 65.7 ± 
11.5 % for the concentration of 50 M. From group 2, com-
pounds 2C and 2D appeared as the most actives, inhibiting 
the NF-kB activation in 30.2 ± 5.6 % and 26.5 ± 3.7 %, re-
spectively, for the concentration of 50 M. 2-SC from group 
3 revealed similar activities. Overall, compounds 1C, 2C and 
2D were the most potent and were able to significantly re-
duce the NF-kB activation induced by stimulation with LPS, 
compound 1C being the most effective of all. Therefore, this 
compound was tested at smaller concentrations exhibiting a 
concentration-dependent effect, which was still significant at 
25 M (Fig. 2). The other tested 2-SC rendered an inhibition 
of NF-kB activation lower than 20 %. 
3.2. Cytokines/Chemokine Production 
The three compounds that inhibited NF-kB activation, 
1C, 2C and 2D, were tested at the 50 M concentration for 
their ability to reduce proinflammatory cytokines/chemo-
kine production. All of them were capable of inhibit the pro-
duction of IL-6 almost totally. Moreover, compound 1C sig-
nificantly reduced the production of IL-1, TNF- and IL-8. 
As well compound 2D was able to significantly reduce the 
production of IL-1 and TNF-. The 2-styrylchromone 2C 
also inhibited the production of TNF- in 4.5 ± 2.0%. Still 
compounds 2C and 2D seem to induce the production of IL-
8. The 2-SC 2C also appear to induce IL-1 but in a lower 
extent (Fig. 3). 
3.3. Cytotoxicity 
None of the tested 2-SC, under the concentration of 50 
M, was cytotoxic to THP-1 cells after a 90 min incubation 
period, as verified by the LDH leakage assay. Compounds 
1C, 2C, and 2D were also further incubated for 16 h with the 
cells showing no cytotoxic effect (data not shown).  
 
Fig. (2). Inhibition of LPS-induced NF-kB activation in THP-1 cells by 2-SC (1A-1D, 2A-2D, 3A-3D). Each bar represents the percentage of 
reduction of p-50-dependent chemiluminescence signal relatively to control. The compounds were tested at the concentration of 50 M, ex-
cept where otherwise indicated. The control represents LPS-stimulated cells with DMSO. Each value represents mean±SEM of four experi-
ments. ***P<0.001, **P<0.01, *P<0.05, significantly different from control. 
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4. DISCUSSION 
Monocytes play an important role in initiating innate 
immune responses through the secretion of inflammatory 
mediators, namely cytokines [35]. 
In the present study we used the THP-1 cells because of 
their human origin and ability to perform many of the func-
tions of peripheral blood monocytes. Based on similar results 
of THP-1 and blood monocytes, the use of THP-1 cells al-
lows more reproducibility and the low variation makes them 
very useful for standardizing test and comparisons between 
compounds to be feasible [36]. In addition, THP-1 have been 
previously used to study the inflammatory process [4, 25-
28]. Inflammation is the process developed by the innate 
immunity in response to physical, physiological and/or oxi-
dative stress and is associated with activation of the NF-kB 
signaling pathway, which is conserved in all multicellular 
animals [1]. Furthermore, NF-kB is increasingly recognized 
as a crucial player in many steps of cancer initiation and pro-
gression [1]. The involvement of NF-kB proteins in the de-
velopment of common autoimmune and chronic inflamma-
tory diseases, including rheumatoid arthritis, multiple sclero-
sis, type 1 diabetes mellitus, thyroid autoimmune diseases, 
systemic lupus erythematosus as well as inflammatory bowel 
disease and psoriasis, has been demonstrated by in vitro and 
in vivo data [37]. 
Moreover, accepted therapeutic options such as glucocor-
ticoids, cyclosporine, tacrolimus, non-steroidal anti-
inflammatory drugs (NSAIDs), and sulfasalazine were 
shown to modulate the NF-kB pathway by several mecha-
nisms. In addition, novel therapeutic strategies that specifi-
cally inhibit key elements of this pathway are being devel-
oped, showing some interesting results in animal models of 
the above mentioned diseases, reviewed in [38]. Oxidative 
stress is defined as an imbalance between production of free 
radicals and reactive metabolites, so-called oxidants or reac-
tive oxygen species (ROS), and their elimination by protec-
tive mechanisms, referred to as antioxidants. This imbalance 
leads to damage of important biomolecules and cells, with 
potential impact on the whole organism [39]. Some of the 
studied compounds had previously shown high scavenging 
activity against ROS and reactive nitrogen species (RNS) 
[21]. Redox status has also been shown to have an impact on 
NF-kB regulation [39, 40]. The mechanism for activation of 
NF-kB by ROS is not clear, and the relationship between 
NF-kB and ROS is complex. Numerous polyphenols have 
been shown ascribe to inhibit NF-kB in different cell types. 
For example, quercetin suppresses NF-kB in J774 cells [41]. 
Apigenin blocks LPS stimulation of the NF-kB pathway in 
macrophages [42]. Catechin inhibits phorbol-12-myristate-
13-acetate (PMA)-induced NF-kB activation at multiple 
steps in Jurkat T cells [43]. Acacetin inhibits the NF-kB ac-
tivation in DU145 prostate cancer cells [44]. Luteolin pre-
vents LPS-induced TNF- expression in cardiac myocytes 
through the inhibition of the NF-kB signaling pathway [45]. 
Chrysin suppresses LPS-stimulated proinflammatory re-
sponses by blocking NF-kB in microglia cells [46]. Narin-
genin inhibits NF-kB activity in inflammatory pulmonary 
diseases induced by human neutrophil elastase [47]. How-
ever, the modulation of NF-kB activation by hydroxylated 2-
SC was reported here for the first time. 
The mechanisms of NF-kB activation are complex and 
depend on the activator and on the cell type. Herein we fo-
cused on the LPS-induced NF-kB activation in phagocytic 
cells, namely monocytes. LPS, the major outer membrane 
component present in gram-negative bacteria, consist of a 
lipid core and polysaccharide side chain joined by a covalent 
bond. LPS act as the prototypical endotoxin to promote the 
secretion of proinflammatory cytokines in many cell types. 
LPS is recognized by TLR4, a member of the TLR family. 
TLRs are evolutionarily conserved pattern recognition recep-
tors that recognize unique, essential molecules characteristic 
of various classes of microbes. The function of TLRs as arbi-
trators of self / nonself discrimination highlights their central 
role in innate immunity as well as in the initiation of the 
adaptive immune response [48, 49]. 
Upon binding of LPS to TLR4, the cytoplasmic region of 
the receptor recruits MyD88 (myeloid differentiation pri-
mary response gene 88), which links TLR4 to IL-1 receptor-
associated kinase (IRAK) and TNF receptor-associated fac-
tor-6 (TRAF6) that mediates NF-kB activation. On the other 
hand, the activation of Rac1 and the subsequent production 
of ROS are key steps involved in NF-kB activation and TNF 
 
Fig. (3). Inhibition of LPS-induced production of TNF-, IL-1, IL-6, and IL-8 in THP-1 cells by 2-SC (1C, 2C, and 2D). Each bar repre-
sents the percentage of reduction of the respective cytokine/chemokine-dependent absorption at 450 nm relatively to control. The compounds 
were tested at the concentration of 50 M. The control represents LPS-stimulated cells with DMSO. Each value represents mean±SEM of 
three experiments. ***P<0.001, **P<0.01, *P<0.05, significantly different from control. 
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secretion in macrophages activated with LPS. LPS-induced 
ROS generation and NF-kB activation was shown to be me-
diated by direct interaction of TLR4 with NADPH oxidase 4 
(Nox4), a protein related to the NADPH oxidase 2 (Nox2) 
present in phagocytic cells, although another Nox enzyme 
might be involved [40]. 
While the mechanism of NF-kB inhibition has been con-
sidered by some to be related to the antioxidant properties of 
the compounds [50, 51], the relevance of these properties to 
the activity of flavonoids was questioned by Comalada and 
coleagues [52] based on the observation that a good antioxi-
dant like kaempferol was a worse NF-kB inhibitor than api-
genin, which is a poor antioxidant. A similar situation oc-
curred with 2-SC, i.e., compounds like 1A and 1B, which 
previously showed high ROS scavenging activity [21], could 
not inhibit the LPS-induced NF-kB DNA-binding, while 
compounds 2C and 2D, which are much less active scaven-
gers, were effective in the present study. However, the lack 
of NF-kB inhibitory activity of good ROS scavengers such 
as 1A and 1B might be related to their poorer hydrophobic-
ity, compared with the active compounds 1C, 2C and 2D,
which can difficult their entry into cells. This rational comes 
in line with the results from a previous study [20], in which 
compounds 1A-1D were tested for their inhibitory effect on 
Cu2+-induced oxidation of isolated human serum low density 
lipoproteins (LDL), an in vitro model of lipid peroxidation. 
In that work, compounds 1C and 1D were much more effec-
tive than 1A and 1B. The unexpected differences observed in 
the antioxidant effectiveness were suggested to be due to the 
different partitioning of 2-SC into LDL as a function of the 
number of hydroxyl groups in the molecule. The authors 
studied the interaction of the SCs with the LDL by absorp-
tion and fluorescence spectroscopies and concluded that the 
less substituted ones interacted with the LDL in more than 
one site, enhancing their activity. Moreover, Brennan and 
Oneill [53] exposed the hypothesis that the reactive oxygen 
model of NF-kB activation depends on the type of cells un-
der study. In their study they reported different susceptibility 
of Jurkat, EL4 and KB cells to the antioxidant N-
acetylcystein, which also did not inhibit TNF-activated NF-
kB in KB cells. 
It is important to note that none of the tested 2-SC under 
the concentration of 50 M was cytotoxic to THP-1 cells as 
it was seen by LDH leakage assay. LDH is a cytosolic en-
zyme that is released when the plasma membrane is damaged 
[54]. 
The transcription factor NF-kB is responsible for the 
regulation of genes encoding proinflammatory cytokines 
[e.g., TNF-a, IL-1, IL-2, IL-6, IL-12, lymphotoxin (LT)a, 
LTb and granulocyte macrophage colony-stimulating factor 
(GM-CSF)], chemokines [e.g., IL-8, macrophage inflamma-
tory protein (MIP)-1a, monocyte chemoattractant protein 
(MCP)-1, regulated on activation, normal T Cell expressed 
and secreted (RANTES) and eotaxin], adhesion molecules 
[e.g., intercellular adhesion molecule (ICAM), vascular cell 
adhesion molecule (VCAM) and E-selectin], growth factors 
and inducible enzymes such as COX-2 and inducible nitric 
oxide synthase (iNOS) [55]. We focus our study in the effect 
of 2-SC in proinflammatory cytokines TNF-, IL-1, and IL-
6 and the chemokine IL-8 since they are known to be impli-
cated in chronic inflammatory and autoimmune diseases 
such as rheumatoid arthritis, multiple sclerosis, and inflam-
matory bowel disease [5-8]. Furthermore, the clinical effi-
cacy of drugs that target TNF-, IL-1, and IL-6 (e.g. mono-
clonal antibodies, receptor antagonists) has been well dem-
onstrated in rheumatoid arthritis and Crohn’s disease [5, 56-
58]. The results obtained in this work show that 1C is capa-
ble of reducing the production of TNF-, IL-1, IL-6, and 
IL-8, most likely by the previous inhibition of NF-kB activa-
tion. 2D, however, was unable to reduce IL-8 production. 
The same happened with 2C, which could not reduce IL-1
production as well. The fact that these two compounds were 
less potent inhibitors of NF-kB activation than 1C may be an 
explanation for the different results. 
In this study, new inhibitors of NF-kB activity were 
found. From all the tested compounds, 1C showed the high-
est activity in inhibiting this transcription factor and was also 
the best in reducing the production of all proinflammatory 
cytokines/chemokine tested. Thus, compound 1C is a prom-
ising scaffold for the development of new anti-inflammatory 
drugs. 
CONFLICT OF INTEREST 
The authors confirm that this article content has no con-
flict of interest. 
ACKNOWLEDGEMENTS 
The authors acknowledge Fundação para a Ciência e 
Tecnologia (FCT) and FEDER financial support for the pro-
ject POCI/QUI/59284/2004 and the Organic Chemistry Re-
search Unit (nº 62; Univ. Aveiro). Marisa Freitas, Daniela 
Ribeiro and Ana Gomes acknowledges FCT the financial 
support for the Pos-doc grant (SFRH/BPD/76909/2011), and 
for the PhD grants (SFRH/BD/72966/2010 and 
SFRH/BD/23299/2005, respectively) in the ambit of “POPH 
- QREN - Tipologia 4.1 - Formação Avançada” co-
sponsored by FSE and national funds of MCTES. 
REFERENCES 
[1] Hoesel, B.; Schmid, J.A. The complexity of NF-kappa B signaling 
in inflammation and cancer. Mol. Cancer, 2013, 12(86), 1-15. 
[2] Bours, V.; Bonizzi, G.; Bentires-Alj, M.; Bureau, F.; Piette, J.; 
Lekeux, P.; Merville, M.P. NF-kappa B activation in response to 
toxical and therapeutical agents: role in inflammation and cancer 
treatment. Toxicology, 2000, 153(1-3), 27-38. 
[3] Palsson-McDermott, E.M.; O'Neill, L.A.J. Signal transduction by 
the lipopolysaccharide receptor, Toll-like receptor-4. Immunology,
2004, 113(2), 153-162. 
[4] Aikawa, Y.; Yamamoto, M.; Yamamoto, T.; Morimoto, K.; 
Tanaka, K. An anti-rheumatic agent T-614 inhibits NF-kappa B 
activation in LPS- and TNF-alpha-stimulated THP-1 cells without 
interfering with 1 kappa B alpha degradation. Inflamm. Res., 2002,
51(4), 188-194. 
[5] Burger, D.; Dayer, J.M.; Palmer, G.; Gabay, C. Is IL-1 a good 
therapeutic target in the treatment of arthritis? Best Pract. Res. 
Clin. Rheumatol., 2006, 20(5), 879-896. 
[6] Feldmann, M.; Brennan, F.M.; Maini, R.N. Role of cytokines in 
rheumatoid arthritis. Annu. Rev. Immunol., 1996, 14, 397-440. 
[7] Kollias, G.; Douni, E.; Kassiotis, G.; Kontoyiannis, D. The 
function of tumour necrosis factor and receptors in models of 
multi-organ inflammation, rheumatoid arthritis, multiple sclerosis 
and inflammatory bowel disease. Ann. Rheum. Dis., 1999, 58, 32-
39. 
2-Styrylchromones Effects in THP-1 Monocytes Medicinal Chemistry, 2015, Vol. 11, No. 6      565
[8] Ishihara, K.; Hirano, T. IL-6 in autoimmune disease and chronic 
inflammatory proliferative disease. Cytokine Growth Factor Rev., 
2002, 13(4-5), 357-368. 
[9] Yang, L.; Qiao, L.R.; Xie, D.; Yuan, Y.H.; Chen, N.H.; Dai, J.G.; 
Guo, S.X. 2-(2-Phenylethyl)chromones from Chinese eaglewood. 
Phytochemistry, 2012, 76, 92-97. 
[10] Gerwick, W.H. 6-Desmethoxyhormothamnione, a new cytotoxic 
styrylchromone from the marine cryptophyte Chrysophaeum 
taylori. J. Nat. Prod., 1989, 52(2), 252-256. 
[11] Gerwick, W.H.; Lopez, A.; Vanduyne, G.D.; Clardy, J.; Ortiz, W.; 
Baez, A. Hormothamnione, a novel cytotoxic styrylchromone from 
the Marine Cyanophyte Hormothamnion-Enteromorphoides 
Grunow. Tetrahedron Lett., 1986, 27(18), 1979-1982. 
[12] Momoi, K.; Sugita, Y.; Ishihara, M.; Satoh, K.; Kikuchi, H.; 
Hashimoto, K.; Yokoe, I.; Nishikawa, H.; Fujisawa, S.; Sakagami, 
H. Cytotoxic activity of styrylchromones against human tumor cell 
lines. In Vivo, 2005, 19(1), 157-163. 
[13] Shaw, A.Y.; Chang, C.Y.; Liau, H.H.; Lu, P.J.; Chen, H.L.; Yang, 
C.N.; Li, H.Y. Synthesis of 2-styrylchromones as a novel class of 
antiproliferative agents targeting carcinoma cells. Eur. J. Med. 
Chem., 2009, 44(6), 2552-2562. 
[14] Doria, G.; Romeo, C.; Forgione, A.; Sberze, P.; Tibolla, N.; Corno, 
M.L.; Cruzzola, G.; Cadelli, G. Anti-allergic agents .3. Substituted 
trans-2-ethenyl-4 oxo-4h-1-benzopyran-6-carboxylic acids. Eur. J. 
Med. Chem., 1979, 14(4), 347-351. 
[15] Conti, C.; Mastromarino, P.; Goldoni, P.; Portalone, G.; Desideri, 
N. Synthesis and anti-rhinovirus properties of fluoro-substituted 
flavonoids. Antivir. Chem. Chemother., 2005, 16(4), 267-276. 
[16] Desideri, N.; Conti, C.; Mastromarino, P.; Mastropaolo, F. 
Synthesis and anti-rhinovirus activity of 2-styrylchromones. 
Antivir. Chem. Chemother., 2000, 11(6), 373-381. 
[17] Rocha-Pereira, J.; Cunha, R.; Pinto, D.C.G.A.; Silva, A.M.S.; 
Nascimento, M.S. (E)-2-Styrylchromones as potential anti-
norovirus agents. Bioorgan. Med. Chem., 2010, 18(12), 4195-4201. 
[18] Fernandes, E.; Carvalho, F.; Silva, A.M.S.; Santos, C.M.M.; Pinto, 
D.C.G.A.; Cavaleiro, J.A.S.; Bastos, M.D. 2-styrylchromones as 
novel inhibitors of xanthine oxidase. A structure-activity study. J. 
Enzym. Inhib. Med. Ch., 2002, 17(1), 45-48. 
[19] Fernandes, E.; Carvalho, M.; Carvalho, F.; Silva, A.M.S.; Santos, 
C.M.M.; Pinto, D.C.G.A.; Cavaleiro, J.A.S.; Bastos, M.D. 
Hepatoprotective activity of polyhydroxylated 2-styrylchromones 
against tert-butylhydroperoxide induced toxicity in freshly isolated 
rat hepatocytes. Arch. Toxicol., 2003, 77(9), 500-505. 
[20] Filipe, P.; Silva, A.M.S.; Morliere, P.; Brito, C.M.; Patterson, L.K.; 
Hug, G.L.; Silva, J.N.; Cavaleiro, J.A.S.; Maziere, J.C.; Freitas, 
J.P.; Santus, R. Polyhydroxylated 2-styrylchromones as potent 
antioxidants. Biochem. Pharmacol., 2004, 67(12), 2207-2218. 
[21] Gomes, A.; Fernandes, E.; Silva, A.M.S.; Santos, C.M.M.; Pinto, 
D.C.G.A.; Cavaleiro, J.A.S.; Lima, J.L.F.C. 2-Styrylchromones: 
Novel strong scavengers of reactive oxygen and nitrogen species. 
Bioorgan. Med. Chem., 2007, 15(18), 6027-6036. 
[22] Gomes, A.; Fernandes, E.; Silva, A.M.S.; Pinto, D.C.G.A.; Santos, 
C.M.M.; Cavaleiro, J.A.S.; Lima, J.L.F.C. Anti-inflammatory 
potential of 2-styrylchromones regarding their interference with 
arachidonic acid metabolic pathways. Biochem. Pharmacol., 2009,
78(2), 171-177. 
[23] Kim, J.S.; Jobin, C. The flavonoid luteolin prevents 
lipopolysaccharide-induced NF-kappa B signalling and gene 
expression by blocking I kappa B kinase activity in intestinal 
epithelial cells and bone-marrow derived dendritic cells. 
Immunology, 2005, 115(3), 375-387. 
[24] Gomes, A.; Fernandes, E.; Lima, J.L.F.C.; Mira, L.; Corvo, M.L. 
Molecular mechanisms of anti-inflammatory activity mediated by 
flavonoids. Curr. Med. Chem., 2008, 15(16), 1586-1605. 
[25] Zhao, Y.; Joshi-Barve, S.; Barve, S.; Chen, L.H. Eicosapentaenoic 
acid prevents LPS-induced TNF-alpha expression by preventing 
NF-kappa B activation. J. Am. Coll. Nutr., 2004, 23(1), 71-78. 
[26] Yeh, C.C.; Kao, S.J.; Lin, C.C.; Wang, S.D.; Liu, C.J.; Kao, S.T. 
The immunomodulation of endotoxin-induced acute lung injury by 
hesperidin in vivo and in vitro. Life Sci., 2007, 80(20), 1821-1831. 
[27] Lee, E.H.; Rikihisa, Y. Absence of tumor necrosis factor alpha, 
interleukin-6 (IL-6), and granulocyte-macrophage colony-
stimulating factor expression but presence of IL-1 beta, IL-8, and 
IL-10 expression in human monocytes exposed to viable or killed 
Ehrlichia chaffeensis. Infect. Immun., 1996, 64(10), 4211-4219. 
[28] Berg, J.; Fellier, H.; Christoph, T.; Grarup, J.; Stimmeder, D. The 
analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, 
inducible nitric oxide synthase (iNOS), and the formation of 
interleukin (IL)-6 in vitro. Inflamm. Res., 1999, 48(7), 369-379. 
[29] Santos, C.M.M.; Silva, A.M.S.; Cavaleiro, J.A.S. Synthesis of new 
hydroxy-2-styrylchromones. Eur. J. Org. Chem., 2003, 23, 4575-
4585. 
[30] Baker, W. Molecular rearrangement of some o-
acyloxyacetophenones and the mechanism of the production of 3-
acylchromones. J. Chem. Soc., 1933, 1381-1389. 
[31] Mahal, H.S.; Venkataraman, K. Synthetical experiments in the 
chromone group Part XIV The action of sodamide on l-acyloxy-2-
acetonaphthones. J. Chem. Soc., 1934, 1767-1769. 
[32] Price, W.A.; Silva, A.M.S.; Cavaleiro, J.A.S. 2-Styrylchromones - 
Biological Action, Synthesis and Reactivity. Heterocycles, 1993,
36(11), 2601-2612. 
[33] Freitas, M.; Fernandes, E. Zinc, cadmium and nickel increase the 
activation of NF-kappa B and the release of cytokines from THP-1 
monocytic cells. Metallomics, 2011, 3(11), 1238-1243. 
[34] Capela, J.P.; Ruscher, K.; Lautenschlager, M.; Freyer, D.; Dirnagl, 
U.; Gaio, A.R.; Bastos, M.L.; Meisel, A.; Carvalho, F. Ecstasy-
induced cell death in cortical neuronal cultures is serotonin 2A-
receptor-dependent and potentiated under hyperthermia. 
Neuroscience, 2006, 139(3), 1069-1081. 
[35] Spahn, J.H.; Kreisel, D. Monocytes in sterile inflammation: 
recruitment and functional consequences. Arch. Immunol. Ther. 
Exp. (Warsz), 2014, 62(3), 187-194. 
[36] Heil, T.L.; Volkmann, K.R.; Wataha, J.C.; Lockwood, P.E. Human 
peripheral blood monocytes versus THP-1 monocytes for in vitro
biocompatibility testing of dental material components. J. Oral. 
Rehabil., 2002, 29(5), 401-407. 
[37] Tripathi, P.; Aggarwal, A. NF-kB transcription factor: a key player 
in the generation of immune response. Curr. Sci. India, 2006,
90(4), 519-531. 
[38] Kurylowicz, A.; Nauman, J. The role of nuclear factor-kappa B in 
the development of autoimmune diseases: a link between genes and 
environment. Acta Biochim. Pol., 2008, 55(4), 629-647. 
[39] Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. 
Oxidative stress, inflammation, and cancer: how are they linked? 
Free Radic. Biol. Med., 2010, 49(11), 1603-1616. 
[40] Gloire, G.; Legrand-Poels, S.; Piette, J. NF-kappa B activation by 
reactive oxygen species: Fifteen years later. Biochem. Pharmacol.,
2006, 72(11), 1493-1505. 
[41] Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; 
Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, 
kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappa 
B activations, whereas flavone, isorhamnetin, naringenin, and 
pelargonidin inhibit only NF-kappa B activation along with their 
inhibitory effect on iNOS expression and NO production in 
activated macrophages. Mediat. Inflamm., 2007, 2007, 1-10. 
[42] Nicholas, C.; Batra, S.; Vargo, M.A.; Voss, O.H.; Gavrilin, M.A.; 
Wewers, M.D.; Guttridge, D.C.; Grotewold, E.; Doseff, A.I. 
Apigenin blocks lipopolysaccharide-induced lethality in vivo and 
proinflammatory cytokines expression by inactivating NF-kappa B 
through the suppression of p65 phosphorylation. J. Immunol., 2007,
179(10), 7121-7127. 
[43] Mackenzie, G.G.; Carrasquedo, F.; Delfino, J.M.; Keen, C.L.; 
Fraga, C.G.; Oteiza, P.I. Epicatechin, catechin, and dimeric 
procyanidins inhibit PMA-induced NF-kappaB activation at 
multiple steps in Jurkat T cells. FASEB J., 2004, 18(1), 167-169. 
[44] Shen, K.H.; Hung, S.H.; Yin, L.T.; Huang, C.S.; Chao, C.H.; Liu, 
C.L.; Shih, Y.W. Acacetin, a flavonoid, inhibits the invasion and 
migration of human prostate cancer DU145 cells via inactivation of 
the p38 MAPK signaling pathway. Mol. Cell. Biochem., 2010,
333(1-2), 279-291. 
[45] Lv, L.H.; Lv, L.H.; Zhang, Y.B.; Kong, Q.H. Luteolin Prevents 
LPS-Induced TNF-alpha Expression in Cardiac Myocytes Through 
Inhibiting NF-kappa B Signaling Pathway. Inflammation, 2011,
34(6), 620-629. 
[46] Ha, S.K.; Moon, E.; Kim, S.Y. Chrysin suppresses LPS-stimulated 
proinflammatory responses by blocking NF-kappa B and JNK 
activations in microglia cells. Neurosci. Lett., 2010, 485(3), 143-
147. 
[47] Yang, J.; Li, Q.; Zhou, X.D.; Kolosov, V.P.; Perelman, J.M. 
Naringenin attenuates mucous hypersecretion by modulating 
reactive oxygen species production and inhibiting NF-kappa B 
566     Medicinal Chemistry, 2015, Vol. 11, No. 6 Gomes et al. 
activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human 
airway epithelial cells. Mol. Cell. Biochem., 2011, 351(1-2), 29-40. 
[48] Yang, L.Y.; Francois, F.; Pei, Z.H. Molecular Pathways: 
Pathogenesis and Clinical Implications of Microbiome Alteration 
in Esophagitis and Barrett Esophagus. Clin. Cancer Res., 2012,
18(8), 2138-2144. 
[49] Sen, R.; Smale, S.T. Selectivity of the NF-kappa B Response. Csh 
Perspect. Biol., 2010, 2(4), 1-15. 
[50] Asehnoune, K.; Strassheim, D.; Mitra, S.; Kim, J.Y.; Abraham, E. 
Involvement of reactive oxygen species in Toll-like receptor 4-
dependent activation of NF-kappa B. J. Immunol., 2004, 172(4), 
2522-2529. 
[51] Ryan, K.A.; Smith, M.F.; Sanders, M.K.; Ernst, P.B. Reactive 
oxygen and nitrogen species differentially regulate toll-like 
receptor 4-mediated activation of NF-kappa B and interleukin-8 
expression. Infect. Immun., 2004, 72(4), 2123-2130. 
[52] Comalada, M.; Ballester, I.; Bailon, E.; Sierra, S.; Xaus, J.; Galvez, 
J.; de Medina, F.S.; Zarzuelo, A. Inhibition of pro-inflammatory 
markers in primary bone marrow-derived mouse macrophages by 
naturally occurring flavonoids: analysis of the structure-activity 
relationship. Biochem. Pharmacol., 2006, 72(8), 1010-1021. 
[53] Brennan, P.; Oneill, L.A.J. Effects of Oxidants and Antioxidants on 
Nuclear Factor Kappa-B Activation in 3 Different Cell-Lines - 
Evidence against a Universal Hypothesis Involving Oxygen 
Radicals. Bba-Gene Struct. Expr., 1995, 1260(2), 167-175. 
[54] Chan, F.K.; Moriwaki, K.; De Rosa, M.J. Detection of necrosis by 
release of lactate dehydrogenase activity. Methods Mol. Biol.,
2013, 979, 65-70. 
[55] Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and 
oxidative stress. Curr. Med. Chem., 2005, 12(10), 1161-1208. 
[56] Feldmann, M.; Maini, R.N. TNF defined as a therapeutic target for 
rheumatoid arthritis and other autoimmune diseases. Nat. Med.,
2003, 9(10), 1245-1250. 
[57] Rutgeerts, P.; Van Assche, G.; Vermeire, S. Optimizing anti-TNF 
treatment in inflammatory bowel disease. Gastroenterology, 2004,
126(6), 1593-1610. 
[58] Mima, T.; Nishimoto, N. Current Opinion in Rheumatology. Curr. 
Opin. Rheumatol., 2009, 21(3), 224-230. 
Received: June 03, 2014 Revised: February 03, 2015   Accepted: February 03, 2015 
